Growth Metrics

Regenerative Medical Technology (RMTG) Non-Current Debt (2019 - 2025)

Historic Non-Current Debt for Regenerative Medical Technology (RMTG) over the last 7 years, with Q3 2025 value amounting to $16.9 million.

  • Regenerative Medical Technology's Non-Current Debt rose 21712860.26% to $16.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year increase of 21712860.26%. This contributed to the annual value of $2.0 million for FY2024, which is 2554101.28% up from last year.
  • Regenerative Medical Technology's Non-Current Debt amounted to $16.9 million in Q3 2025, which was up 21712860.26% from $2.8 million recorded in Q2 2025.
  • In the past 5 years, Regenerative Medical Technology's Non-Current Debt registered a high of $16.9 million during Q3 2025, and its lowest value of $7800.0 during Q1 2021.
  • For the 5-year period, Regenerative Medical Technology's Non-Current Debt averaged around $3.7 million, with its median value being $7800.0 (2021).
  • As far as peak fluctuations go, Regenerative Medical Technology's Non-Current Debt tumbled by 9994.05% in 2023, and later soared by 21712860.26% in 2025.
  • Over the past 5 years, Regenerative Medical Technology's Non-Current Debt (Quarter) stood at $11.8 million in 2021, then crashed by 99.93% to $7800.0 in 2022, then changed by 0.0% to $7800.0 in 2023, then surged by 25541.01% to $2.0 million in 2024, then skyrocketed by 747.19% to $16.9 million in 2025.
  • Its Non-Current Debt stands at $16.9 million for Q3 2025, versus $2.8 million for Q2 2025 and $2.0 million for Q1 2025.